Third-party Study Report: Pump Particle Shedding Evaluation
Exhibitor: LEVITRONIX GMBH TAIWAN BRANCH
Date: 2022-08-01
Booth No.: R1101
Pump Particle Shedding Evaluation
Keywords:
- Bioprocessing
- Pump Comparison
- Peristaltic Pump
- 4-Piston Diaphragm Pump
- Particle Shedding
Facts
Peristaltic and 4-piston diaphragm pumps are based on mechanical contact between moving parts such as tube compression or valve interaction. Mechanical contact between moving parts can lead to particle shedding, which leads to product contamination.
Levitronix® pumps have no mechanical contact between moving parts.
Test conditions
The Levitronix® PuraLev® 600SU pump, a 4-Piston Diaphragm Pump, and a peristaltic pump were evaluated for particle shedding. A fixed volume of ultrapure water was recirculated by each pump at a flow rate of 16 l/min and backpressures of 1 and 2.5 bar, respectively. The particle level was measured at selected times and compared.
Results
The peristaltic and 4-Piston Diaphragm pumps generated particle levels 2-3 orders of magnitude greater than the PuraLev® 600SU pump. Regardless of operating conditions, the concentration of particles downstream of the Levitronix® pump was near the detected background-level for the system.
Cumulative particle size distributions at 16 lpm and 2.5 bar
Reference Details: Pump Particle Shedding Evaluation - Levitronix
More Exhibitor's Press Release
- Home Visual Acuity tester- Don't let pseudomyopia become real myopia EYEMIKAN BIOTECH INC. / 2022-09-21
- Third-party Study Report: Investigation of Shear Stress Exerted on Proteins by Different Pump System LEVITRONIX GMBH TAIWAN BRANCH / 2022-08-01
- Third-party Study Report: Investigation of Shear Stress Exerted on CHO Cell by Different Pump System LEVITRONIX GMBH TAIWAN BRANCH / 2022-08-01
- Bio Asia-Taiwan 2022 Opening! Vitae Biomedical showcases the new outstanding achievements. VITAE BIOMEDICAL CO. LTD. / 2022-07-30
- Joint Genomic Analytics Platform from Advantech, GARAOTUS and WASAI GARAOTUS (SYSTEX GROUP) / 2022-07-30
- FDA Grants the Pre-EUA Meeting Request by GoldenBiotech’s Applied Antroquinonol to Treat COVID GOLDEN BIOTECHNOLOGY CORP. / 2022-07-30
- Antroquinonol, Committed to Innovative & Breakthrough Therapy to Improve Quality of Life GOLDEN BIOTECHNOLOGY CORP. / 2022-07-30
- Italy participates for the third time in BIO ASIA with 7 companies ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2022-07-29
- AcadeMab makes its mark at 2022 BIO USA ACADEMAB BIOMEDICAL INC. / 2022-07-28
- Taiwan's AcadeMab develops groundbreaking therapy for COVID-19 Omicron variant with potent neutraliz ACADEMAB BIOMEDICAL INC. / 2022-07-28
- CAMCEVI 42 mg Injection Emulsion Launched in the U.S. for the Treatment of Advanced Prostate Cancer FORESEE PHARMACEUTICALS CO., LTD. / 2022-07-27
- Foresee Announces European MAA Approval of CAMCEVI for the the Treatment of Advanced Prostate Cancer FORESEE PHARMACEUTICALS CO., LTD. / 2022-07-27
- TaiMed is your reliable biologics CDMO partner TAIMED BIOLOGICS INC. / 2022-07-27
- US FDA NDIN approval for Deglusterol, a new dietary ingredient for blood sugar control CAREGEN CO., LTD. / 2022-07-27
- 2022BioAsiaTaiwan-Golden Biotech Seminar Registration_Innovative Breakthrough_COVID-19 to Oncology GOLDEN BIOTECHNOLOGY CORP. / 2022-07-27
- Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan AMARAN BIOTECHNOLOGY, INC. / 2022-07-25
- "Montefarmaco’s portfolio covers the main segments of the self-medication market" MONTEFARMACO OTC SPA / 2022-07-22
- TMU BioMed Accelerator | 2022 Batch Demo Day (Register Now) TAIPEI MEDICAL UNIVERSITY / 2022-07-22
- BUCHI wins Swiss Export Award 2022 BUCHI TAIWAN CO., LTD. / 2022-07-21
- Automation and innovative design of BUCHI’s new Spray Dryer markedly improve spray drying performanc BUCHI TAIWAN CO., LTD. / 2022-07-21
